Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Issues And Trends In Healthcare Delivery System01:29

Issues And Trends In Healthcare Delivery System

6.1K
The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
6.1K
Neural Regulation01:37

Neural Regulation

42.9K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
42.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Psychedelic Therapies Executive Order: On Approval and Clinical Readiness.

JAMA·2026
Same author

Shifting Tasks, Shifting Baselines: Mobile Health and the Limits of Empowerment.

The American journal of bioethics : AJOB·2026
Same author

When Patients Share Everything With an AI Chatbot: Risks and Opportunities of Large Language Models.

JAMA·2026
Same author

Ethical Considerations for Heart Organ Allocation: Current Landscape and Future Policy Guidance: A Scientific Statement From the American Heart Association.

Circulation·2026
Same author

Polygenic disease risk scoring and genetic non-discrimination.

Journal of law and the biosciences·2026
Same author

Setting, context and the regulatory atmospheres of psychedelic medicine.

The International journal on drug policy·2026
Same journal

Explainable foundation model for dementia screening and risk stratification using retinal fundus images.

NPJ digital medicine·2026
Same journal

LLM research on public biosignals data is needed to protect patients.

NPJ digital medicine·2026
Same journal

Conversational artificial intelligence for pre-procedural patient preparation: implementation, validation and patient satisfaction.

NPJ digital medicine·2026
Same journal

Whole body CT attenuation and volume charts from routine clinical scans via LLM report filtering.

NPJ digital medicine·2026
Same journal

Fast information and slow evidence in the large language models era.

NPJ digital medicine·2026
Same journal

Predicting response to neoadjuvant therapy using artificial intelligence on digitized histopathology slides: a systematic review.

NPJ digital medicine·2026
See all related articles

Related Experiment Video

Updated: Dec 24, 2025

Introduction of an Integrated Pathology Image Management, Artificial Intelligence, and Reporting System
05:33

Introduction of an Integrated Pathology Image Management, Artificial Intelligence, and Reporting System

Published on: July 11, 2025

681

The need for a system view to regulate artificial intelligence/machine learning-based software as medical device.

Sara Gerke1, Boris Babic2, Theodoros Evgeniou3

  • 11Project on Precision Medicine, Artificial Intelligence, and the Law; Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School, Harvard University, Cambridge, MA USA.

NPJ Digital Medicine
|April 15, 2020
PubMed
Summary
This summary is machine-generated.

Regulators should shift from evaluating single medical artificial intelligence (AI) and machine learning (ML) products to assessing entire AI/ML systems. This system-level view is crucial for ensuring the safety and effectiveness of these evolving healthcare technologies.

Keywords:
Health policyLaw

More Related Videos

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
07:13

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Published on: April 12, 2021

4.8K
Real-Time Proxy-Control of Re-Parameterized Peripheral Signals using a Close-Loop Interface
11:54

Real-Time Proxy-Control of Re-Parameterized Peripheral Signals using a Close-Loop Interface

Published on: May 8, 2021

5.0K

Related Experiment Videos

Last Updated: Dec 24, 2025

Introduction of an Integrated Pathology Image Management, Artificial Intelligence, and Reporting System
05:33

Introduction of an Integrated Pathology Image Management, Artificial Intelligence, and Reporting System

Published on: July 11, 2025

681
Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
07:13

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Published on: April 12, 2021

4.8K
Real-Time Proxy-Control of Re-Parameterized Peripheral Signals using a Close-Loop Interface
11:54

Real-Time Proxy-Control of Re-Parameterized Peripheral Signals using a Close-Loop Interface

Published on: May 8, 2021

5.0K

Area of Science:

  • Medical technology regulation
  • Health informatics
  • Artificial intelligence in healthcare

Background:

  • Artificial intelligence (AI) and Machine Learning (ML) systems offer significant potential to enhance healthcare through improved diagnostics and personalized treatments.
  • The rapid integration of AI/ML in medicine presents regulatory challenges regarding product review, evidence requirements, and ensuring ongoing safety and effectiveness.
  • Existing regulatory frameworks, such as those proposed by the U.S. Food and Drug Administration (FDA), primarily focus on individual products.

Purpose of the Study:

  • To advocate for a shift in regulatory perspective from evaluating individual AI/ML medical products to assessing comprehensive AI/ML systems.
  • To highlight the critical importance of a system-level approach for maximizing the safety and efficacy of AI/ML in healthcare.
  • To address the challenges faced by regulatory bodies like the FDA in transitioning from product-centric to system-centric evaluation.

Main Methods:

  • Analysis of current regulatory approaches to AI/ML in medicine.
  • Critique of product-based evaluation versus system-based evaluation.
  • Development of recommendations for regulatory agencies to adopt a system-view perspective.

Main Results:

  • Current regulatory approaches, exemplified by the FDA's discussion paper, tend to focus on individual AI/ML products.
  • A product-centric view is insufficient for managing the dynamic nature and evolving capabilities of AI/ML systems in healthcare.
  • A system-view approach is essential for robustly ensuring the safety and effectiveness of medical AI/ML over time.

Conclusions:

  • Regulators must broaden their scope beyond individual AI/ML products to encompass the entire system.
  • Transitioning to a system-based regulatory framework is vital for harnessing the full potential of AI/ML in healthcare safely and effectively.
  • Implementing a system-view approach presents significant challenges but is a necessary evolution for regulatory agencies.